Results 121 to 130 of about 3,769 (208)

Modest improvement of metabolic and behavioral deficits with long-term ambroxol treatment in a Pink1^-/-SNCA^A53T double mutant mouse model of Parkinson's disease. [PDF]

Acta Pharmacol Sin
Franck L, Valek L, Hahnefeld L, Trautmann S, Angioni C, Weyer MP, Thomas D, Gurke R, Wittig I, Geisslinger G, Tegeder I.   +10 more
europepmc   +1 more source

The use of genistein and ambroxol may be an effective approach in correcting cellular dysfunctions of mucopolysaccharidosis-plus syndrome. [PDF]

Mamm Genome
Cyske Z, Rintz E, Gaffke L, Pierzynowska K, Węgrzyn G.   +4 more
europepmc   +1 more source

Computational evaluation of EPA-PC binding to GCase in neuronopathic Gaucher disease. [PDF]

Curr Res Struct Biol
Nagori R, Rai PK, Solanki M, Sabharwal U, Patel P.   +4 more
europepmc   +1 more source

Scaffolds for sustained release of ambroxol hydrochloride, a pharmacological Chaperone that Increases the Activity of Misfolded ß-Glucocerebrosidase

Ambroxol is a pharmacological chaperone (PC) for Gaucher disease that increases lysosomal activity of misfolded ß-glucocerebrosidase (GCase) while displaying a safe toxicological profile.
Molina, Brenda G., Saperas Plana, Núria, Estrany Coda, Francesc, Arnan, Carme, Alemán Llansó, Carlos, Enshaei, Hamidreza, Puiggalí Bellalta, Jordi, Valle Mendoza, Luis Javier del   +7 more
core  

Biological, antimicrobial, and apical tissue dissolution effects of ambroxol hydrochloride as an irrigant for regenerative endodontics: an in vitro study. [PDF]

BMC Oral Health
Coelho LAS, Bordini EAF, Cassiano FB, Barros MC, Silva RM, de Andrade FB, Soares DG, Duarte MAH.   +7 more
europepmc   +1 more source

Pustular Rosacea in an 8-Year-Old Patient: A Rare Presentation of Pediatric Rosacea. [PDF]

Case Rep Dermatol Med
Sharaf R, Assaf T, Ghanem UI, Alhameed HA, Adwan R.   +4 more
europepmc   +1 more source

Special Issue "Molecular Application of Mass Spectrometry and Chromatography in Biomedicine". [PDF]

Int J Mol Sci
Ventura G, Bianco M.
europepmc   +1 more source

Pathological Protein Targets in Parkinson's Disease: Progress Towards the Development of Disease-Modifying Therapies. [PDF]

CNS Drugs
Dzamko N.
europepmc   +1 more source

Erratum: Ambroxol enhances anti-cancer effect of microtubule-stabilizing drug to lung carcinoma through blocking autophagic flux in lysosome-dependent way. [PDF]

Am J Cancer Res
Zhang X, Chen Q, Chen M, Ren X, Wang X, Qian J, Sun Y, Sha X.   +7 more
europepmc   +1 more source

A comparative study of the impact of prescription and non-prescription mucolytic agents on respiratory disease management in a community-based population. [PDF]

Front Pharmacol
Dawane JS, Mehetre KN, Shinde J.
europepmc   +1 more source